Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > St Joseph Healthcare,Hamilton Ont.Canada
View:
Post by ramrodretired on Nov 26, 2024 10:31am

St Joseph Healthcare,Hamilton Ont.Canada

I just got back from a appointment too see my urologist  Bobby Shayegan 
head of surgery.
Roger resently called about opening a site at the hospital ,sounds like it is going to happen!
I have very high regard for the doctor
I think this is a great sign !!!!!!!!!
Comment by Dumbeldorfwhite on Nov 26, 2024 10:48am
That's awesome but what's the point if enrollment is set to be complete in 1 month?
Comment by patience69 on Nov 26, 2024 10:56am
Pretty sure if they are enrolling now it is for future trials as you mentioned this one is almost done. Maybe a combo trial with another drug? Or other indications 
Comment by fecats on Nov 26, 2024 10:58am
That's exactly the case . The future is bright , DumDum not so much 
Comment by Dumbeldorfwhite on Nov 26, 2024 11:00am
Anyone want to make a bet that enrollment isn't completed by 2025 ? Maybe some put some shares on the line?
Comment by Dumbeldorfwhite on Nov 26, 2024 11:04am
And why would a Urologist be talking about other indications IE brain or Lung like come on use your head.
Comment by patience69 on Nov 26, 2024 11:24am
What about muscle invasive bladder cancer ?  That is another indication in case you didn't know 
Comment by Dumbeldorfwhite on Nov 26, 2024 11:37am
One that hasn't been mentioned since 2015 if I recall.
Comment by patience69 on Nov 26, 2024 12:16pm
So. What's your point 
Comment by Dumbeldorfwhite on Nov 26, 2024 12:18pm
How dense can u be? Why open another site when enrollment is supposed to be finished in days. If I was a betting man enrollment is not finished and is behind. DUH
Comment by patience69 on Nov 26, 2024 12:50pm
I guess I am dense to think there could be more trials. I'll bet even more get.enrolled in more future trials. Let's have this discussion in the new year and see who is right and who is dense or maybe just who has an agenda 
Comment by fecats on Nov 26, 2024 1:15pm
You are right . New site would not come on board for an almost complete trial . Unless of course they feel more trials will be coming in the future. I guess some people are too narrow minded to understand that . Or else they have an agenda to bash .
Comment by Dumbeldorfwhite on Nov 26, 2024 1:54pm
Why don't we put a little friendly wager on it?
Comment by enriquesuave on Nov 26, 2024 1:57pm
After approval there is always a post approval confirmatory trial
Comment by tdon1229 on Nov 26, 2024 2:17pm
RDW in a recent video noted that the company obviously would not be enrolling all 100 patients in the trial by the end of 2024  Instead, money permitting, the company was shooting for about 85 to be enrolled by the end of 2024.  Interestingly, despite this admission, there was no change made to the headlne information.. Also noted was the intent to open additional clinical trial sites ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250